We’re an NYC-based company conceived in 2011. Our focus is on assisting clinicians and research professionals with our easy-to-use web platform that analyzes raw primary medical data at the point of evaluation. Our flagship cloud-based service is CliniscanSM.
This product enables the clinician and researcher to work in the cloud with a wide range of biomedical modalities.
Today, biomedical professionals are faced with the task of analyzing increasingly diverse and voluminous primary biomedical data and making decisions based on this data. Our products are the solution to this time-consuming task and present a toolbox of biomedical analytics during diagnosis. These analytics can be run instantly, and in parallel, against biomedical data submissions with virtually unlimited scaling capacity. Our services will be provided at competitive prices, underscoring the need for cost-effective digital healthcare solutions.
The delivery of healthcare and evidence-based outcomes are becoming increasingly personalized, in which specific individual information, from physiological to genomic data, are used both in a diagnostic and therapeutic capacity.
Our first product, CliniscanSM EEG Decision Support, will be released in 2015. With an emphasis on open-ended architecture, we expect the number of analytics for each modality to self-proliferate by partnering with imaging groups, hospitals, universities, and research centers. Our subsequent products, addressing complex biomedical modalities such as MRI, PET and CT, are currently under development.
Through our team of highly experienced software developers, biomedical engineers, and mathematicians we’ve developed this technology on a very aggressive schedule since inception—a game-changer in healthcare technology.